Bibliography

Found 30 results

Filters: First Letter Of Last Name is E [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

E

Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis RJ, Cherner M, Gelman B, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693

Everall I, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory ME, Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathology (Zurich, Switzerland) [Internet]. 1999 ;9(2):209-217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10219738

Everall I, Hansen LA, Masliah E. The shifting patterns of HIV encephalitis neuropathology. Neurotoxicity Research [Internet]. 2005 ;8(1-2):51-61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16260385

Everall I, Trillo-Pazos G, Bell C, Mallory ME, Sanders VJ, Masliah E. Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection. Journal of Neuropathology and Experimental Neurology [Internet]. 2001 ;60(3):293-301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11245213

Everall I, Salaria S, Atkinson JH, Young C, Corbeil J, Grant I, Masliah E. Diminished somatostatin gene expression in individuals with HIV and major depressive disorder. Neurology [Internet]. 2006 ;67:1867-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17130427

Everall I, Grant I. Proteomic pointers in HIV neurocognitive disorder. Lancet [Internet]. 2004 ;363(9415):1091-2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15064024

Everall I, Bell C, Mallory ME, Langford D, Adame A, Rockestein E, Masliah E. Lithium ameliorates HIV-gp120-mediated neurotoxicity. Molecular and Cellular Neurosciences [Internet]. 2002 ;21(13):493-501. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12498789

Everall I, Salaria S, Roberts ES, Corbeil J, Sasik R, Fox HS, Grant I, Masliah E. Methamphetamine stimulates interferon inducible genes in HIV infected brain. Journal of Neuroimmunology [Internet]. 2005 ;170(1-2):158-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16249037

Eugenin EA, Morgello S, Klotman ME, Mosoian A, Lento PA, Berman JW, Schecter AD. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. The American Journal of Pathology [Internet]. 2008 ;172:1100-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18310503

Estanislao LB, Morgello S, Simpson DM. Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review. AIDS (London, England) [Internet]. 2005 ;19 Suppl 3:S135-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16251810

Estanislao LB, Morgello S, Dorfman D, Giles K, Baker T, Geraci A, Simpson DM. Diagnosis of HIV– associated distal symmetrical polyneuropathy in the primary care setting. In: Journal of NeuroVirology. Vol. 9. S3th ed. Journal of NeuroVirology. ; 2003. pp. 105-106.

Erichsen D, Lopez AL, Peng H, Niemann D, Williams C, Bauer M, Morgello S, Cotter RL, Ryan LA, Ghorpade A, et al. Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. Journal of Neuroimmunology [Internet]. 2003 ;138(1-2):144-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12742664

Enam S, Sweet TM, Amini S, Khalili K, Del-Valle L. Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. Archives of Pathology & Laboratory Medicine [Internet]. 2004 ;128(3):282-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14987161

Ellis RJ, Heaton RK, Tang B, Collier AC, Marra CM, Gelman BB, Morgello S, Clifford DB, Sacktor N, Cookson D, et al. Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years. Brain Behav Immun Health. 2022 ;21:100437.

Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson DM, Yiannoutsos CT, et al. Clinical validation of the NeuroScreen. Journal of Neurovirology [Internet]. 2005 ;11(6):503-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16338744

Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, Simpson DM, Ake C, Collier AC, Gelman BB, et al. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol. 2008 ;64(5):566-72.

Ellis RJ, Merdes A, Masliah E, Langford TD. Clinical-neuropathological correlation in HIV in the era of highly active antiretroviral therapy. In: Gendelman, H.E.; Grant ELSI ; I ; The Neurology of AIDS. The Neurology of AIDS. London: Oxford University Press; 2005. pp. 799-809.

Ellis RJ, Paolillo E, Saloner R, Heaton RK. Higher Comorbidity Burden Predicts Worsening Neurocognitive Trajectories in People with Human Immunodeficiency Virus. Clin Infect Dis. 2022 ;74(8):1323-1328.

Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, HNRC. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. The Journal of Infectious Diseases [Internet]. 2003 ;188(12):1820-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14673760

Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T, Gelman BB, Vaida F, Collier A, Marra CM, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010 ;67(5):552-8.

Ellis RJ, Sacktor N, Clifford DB, Marra CM, Collier AC, Gelman B, Robinson-Papp J, Letendre SL, Heaton RK. Neuropathic pain correlates with worsening cognition in people with human immunodeficiency virus. Brain. 2022 ;145(6):2206-2213.

Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 ;25(14):1747-51.

Ellis RJ, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nature Reviews. Neuroscience [Internet]. 2007 ;8:33-44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17180161

Ellis RJ, Pal S, Achim CL, Sundermann E, Moore DJ, Soontornniyomkij V, Feldman H. Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach. Res Sq. 2023 .

Ellis RJ, Diaz M, Sacktor N, Marra C, Collier AC, Clifford DB, Calcutt N, Fields JA, Heaton RK, Letendre SL. Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV. Ann Clin Transl Neurol. 2020 ;7(7):1166-1173.

Pages